These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2697988)

  • 1. [Theophylline in the treatment of asthma: indications, use and side effects].
    Slapke J; Hummel S; Wilke A; Wenz W; Meister W; Förster R; Wiesner B; Nussbücker B
    Z Arztl Fortbild (Jena); 1989; 83(22):1097-102. PubMed ID: 2697988
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V; Nicora M; Beretta A
    Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prescription of Theostat 300 as a single evening dose].
    Germouty J; Bida C; Moreau L
    Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Theophylline in asthma and COPD. Saving on inhalational steroids].
    MMW Fortschr Med; 2002 Aug; 144(31-32):54. PubMed ID: 12422740
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical effectiveness of delayed-action theophylline preparations].
    Tsoĭ AN; Gavrilenko LN; Bogovskiĭ BP; Semenova LG; Iuldasheva LI
    Klin Med (Mosk); 1990 Sep; 68(9):72-5. PubMed ID: 2290338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline, a review.
    Rudolph BM
    J Tenn Med Assoc; 1977 Mar; 70(3):171-4. PubMed ID: 839788
    [No Abstract]   [Full Text] [Related]  

  • 9. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Individual theophylline doses following ambulatory determination of theophylline clearance].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1986 Aug; 40(8):334-8. PubMed ID: 3748986
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (Theolair and Theolair retard) in normals and asthmatics. Part II: Lung function and side effects.
    Utama I; Kreukniet J; Fokkens J; Serra R
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):292-6. PubMed ID: 6885203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levels of blood theophylline in patients with acute bronchospasm].
    Martínez MJ; Martínez B; Saucedo R; García Delgado R; García Morillas M; Puche E
    Rev Clin Esp; 1989 May; 184(9):470-2. PubMed ID: 2772324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I
    Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
    [No Abstract]   [Full Text] [Related]  

  • 15. Theophylline in asthma and COPD: changing perspectives and controversies.
    Poe RH; Utell MJ
    Geriatrics; 1991 Apr; 46(4):55-6, 61-5. PubMed ID: 2010095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term therapy with a retard theophylline preparation].
    Keller A; Bömches B; Kandt D
    Fortschr Med; 1995 May; 113(13):197-202. PubMed ID: 7782018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Practicability, effectiveness and tolerance of a standardized prepared theophylline infusion].
    Pohl WR; Kummer F; Lorber H; Würtz J; Aigner K; Pfeiffer KP
    Acta Med Austriaca; 1996; 23(3):105-8. PubMed ID: 8967286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.
    Nolte D; Dusik B
    Br J Clin Pract Suppl; 1984; 32():18-21. PubMed ID: 6432018
    [No Abstract]   [Full Text] [Related]  

  • 19. [Delayed-action theophyllines with "once a day" administration--a new therapeutic tool in asthma and COPD].
    Ulmeanu R; Mihălţan F
    Pneumoftiziologia; 1997; 46(3):223-4. PubMed ID: 9654961
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-effect relationship of a controlled release theophylline preparation in pre-school children.
    Duiverman EJ; Neijens HJ; Kerrebijn KF
    Br J Clin Pract Suppl; 1984; 35():55-6. PubMed ID: 6433962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.